Lightox
Advertisement
65 Westgate Road
Newcastle upon Tyne, England NE1 1SG
LightOx, headquartered in Newcastle upon Tyne, UK, is at the forefront of developing innovative light-activated drug compounds aimed at treating early-stage mouth cancers and precancerous lesions. Their lead candidate is anticipated to enter Phase III clinical trials in 2025, with a focus on improving patient outcomes through novel therapeutic solutions.
The company is pioneering a new class of light-activated chemotherapy that could be administered in a dentist's chair, utilising a gel applied to affected areas, which is activated by light. This method promises to offer a swift and simple alternative to traditional surgery, with fewer side effects.
Generated from the website
Also at this address
See a problem?
You might also like
Advertisement
